These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11582576)

  • 1. Design, synthesis, and conformational study of biologically active photolabeled analogues of the main immunogenic region of the acetylcholine receptor.
    Theodorou V; Tsikaris V; Sakarellos-Daitsiotis M; Avramopoulou V; Kostelidou K; Tzartos SJ; Sakarellos C
    Biopolymers; 2000-2001; 56(1):37-46. PubMed ID: 11582576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach.
    Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT
    Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic lactam analogues containing the main immunogenic region of Torpedo acetylcholine receptor.
    Detsikas E; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Cung MT; Marraud M; Vatzaki E; Tzartos SJ
    Pept Res; 1993; 6(1):17-23. PubMed ID: 7679937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The main immunogenic region of the nicotinic acetylcholine receptor. Identification of amino acid residues interacting with different antibodies.
    Bellone M; Tang F; Milius R; Conti-Tronconi BM
    J Immunol; 1989 Dec; 143(11):3568-79. PubMed ID: 2584708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.
    Jung HH; Yi HJ; Lee SK; Lee JY; Jung HJ; Yang ST; Eu YJ; Im SH; Kim JI
    Biochemistry; 2007 Dec; 46(51):14987-95. PubMed ID: 18052043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198.
    Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E
    Biochem Biophys Res Commun; 2007 May; 356(3):569-75. PubMed ID: 17376405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional 1H-NMR study of antigen-antibody interactions: binding of synthetic decapeptides to an anti-acetylcholine receptor monoclonal antibody.
    Cung MT; Demange P; Marraud M; Tsikaris V; Sakarellos C; Papadouli I; Kokla A; Tzartos SJ
    Biopolymers; 1991 May; 31(6):769-76. PubMed ID: 1932573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.
    Wahlsten JL; Lindstrom JM; Ostlie N; Wu XD; Conti-Tronconi BM
    J Recept Res; 1993; 13(5):863-79. PubMed ID: 8463998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
    Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI
    FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compared structures of the free nicotinic acetylcholine receptor main immunogenic region (MIR) decapeptide and the antibody-bound [A76]MIR analogue: a molecular dynamics simulation from two-dimensional NMR data.
    Orlewski P; Marraud M; Cung MT; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ
    Biopolymers; 1996; 40(5):419-32. PubMed ID: 9062066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution conformation of the antibody-bound tyrosine phosphorylation site of the nicotinic acetylcholine receptor beta-subunit in its phosphorylated and nonphosphorylated states.
    Phan-Chan-Du A; Hemmerlin C; Krikorian D; Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Marinou M; Thureau A; Cung MT; Tzartos SJ
    Biochemistry; 2003 Jun; 42(24):7371-80. PubMed ID: 12809492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The main immunogenic region of the acetylcholine receptor. Structure and role in myasthenia gravis.
    Tzartos SJ; Barkas T; Cung MT; Kordossi A; Loutrari H; Marraud M; Papadouli I; Sakarellos C; Sophianos D; Tsikaris V
    Autoimmunity; 1991; 8(4):259-70. PubMed ID: 1718457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor.
    Papadouli I; Potamianos S; Hadjidakis I; Bairaktari E; Tsikaris V; Sakarellos C; Cung MT; Marraud M; Tzartos SJ
    Biochem J; 1990 Jul; 269(1):239-45. PubMed ID: 1695844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor.
    Tzartos SJ; Barkas T; Cung MT; Mamalaki A; Marraud M; Orlewski P; Papanastasiou D; Sakarellos C; Sakarellos-Daitsiotis M; Tsantili P; Tsikaris V
    Immunol Rev; 1998 Jun; 163():89-120. PubMed ID: 9700504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.